Pfizer Inc. (PFE): Book A 120% Gain With This Pharma Stock’s Rebound
One of the strongest market sectors this year has been pharmaceuticals.
Posts Tagged ‘NYSE:PFE’
Onyx Pharmaceuticals, Inc. (ONXX), Alexion Pharmaceuticals, Inc. (ALXN): 3 Biotechs That Could Be Bought Out This Year
Chances are that a few biotech companies will be scooped up by larger players over the coming months.
GlaxoSmithKline plc (ADR) (GSK), Theravance Inc (THRX), Pfizer Inc. (PFE): 3 Potential Game Changers for COPD
Over 13 million Americans have it. More than 120,000 of them die every year.
Pfizer Inc. (PFE), Cliffs Natural Resources Inc (CLF), Intel Corporation (INTC): Short Sellers Have These Seven Well-Known Stocks In Their Sights
Indeed, many hedge fund managers that tend to make a living from short selling have moved to the sidelines, waiting for the market to switch direction before loading up on shorts...
Exxon Mobil Corporation (XOM), AT&T Inc. (T), Apple Inc. (AAPL): These 15 Stocks Are the Most Generous Dividend-Payers in the Market
Dividend stocks have gotten incredibly popular among investors as the search for income has led many to take on more risk in their portfolios in order to generate the cash flow...
Amgen, Inc. (AMGN), DaVita HealthCare Partners Inc (DVA): Four Robust Investments in Dialysis and Diabetes
Shares of the two largest kidney care companies in the United States, DaVita HealthCare Partners Inc (NYSE:DVA) and Fresenius Medical Care AG & Co.
Pharmacyclics, Inc. (PCYC): Will This Be the Breakthrough of All Breakthrough Therapy Drugs?
In July 2012, the Food and Drug Administration Safety and Innovation Act was signed into law; and little did we know at the time, but the drug development process was about to...
Exploding Pipeline Makes BioMarin Pharmaceutical Inc. (BMRN) Attractive Takeover Target
The Orphan Drug pipeline of BioMarin Pharmaceutical Inc.
Microsoft Corporation (MSFT), Pfizer Inc. (PFE), and Northrop Grumman Corporation (NOC): Three Good Companies With Unloved Stocks
The co-managers of Guinness Atkinson Inflation Managed Dividend Fund (GAINX) describe Microsoft Corporation (NASDAQ:MSFT), Pfizer Inc. (NYSE:PFE), and Northrop Grumman Corporation...
Drug Deal Can Only Help VIVUS, Inc. (VVUS) So Much
VIVUS, Inc. (NASDAQ:VVUS) has found an Italian to help it out.
Who Could Buy Onyx Pharmaceuticals, Inc. (ONXX) and at What Price?
Recently Onyx Pharmaceuticals, Inc. (NASDAQ:ONXX) rejected a $10 billion takeover offer from Amgen, Inc. (NASDAQ:AMGN).
Alcoa Inc (AA), Intel Corporation (INTC): The Dow Jones Industrial Average (.DJI)’s 5 Most Hated Stocks
What happens when the unstoppable force known as the Dow Jones Industrial Average (Dow Jones Indices:.DJI) meets the immovable object known as short-sellers? Thus far, the answer...
Is Merck & Co., Inc. (MRK) Destined for Greatness?
Investors love stocks that consistently beat the Street without getting ahead of their fundamentals and risking a meltdown.
Gilead Sciences, Inc. (GILD), Johnson & Johnson (JNJ): Is a Breakthrough Treatment on the Way for People With HIV?
We as a country have a come a long way over the past two decades with regard to treating HIV and reducing the number of AIDS diagnoses.
DaVita HealthCare Partners Inc (DVA), Fresenius Medical Care AG & Co. (ADR) (FMS), Merck & Co., Inc. (MRK): Four Robust Investments in Dialysis and Diabetes
Shares of the two largest kidney care companies in the United States, DaVita HealthCare Partners Inc (NYSE:DVA) and Fresenius Medical Care AG & Co.
GlaxoSmithKline plc (ADR) (GSK): Why You Should Buy This European Healthcare Company
Investors who buy stock in the major pharmaceutical companies likely do so because of several factors, including steady growth, modest valuations, and high dividend yields.
Antares Pharma Inc (ATRS): A Critical Look
Recently, I enjoyed an article contributed by Adam Feuerstein ("AF article") regarding Antares Pharma Inc (NASDAQ:ATRS) and its transformational product Otrexup.
Johnson & Johnson (JNJ): Why Will This “Boring” Healthcare Company Produce Exciting Gains in Your Portfolio?
When it comes to investing for the long term, sometimes companies that are thought of as “stable” or “boring” turn out to be the best thing for your portfolio.
How Much Is Onyx Pharmaceuticals, Inc. (ONXX) Really Worth?
The promising cancer developer confirmed over the weekend that Amgen had made an offer to acquire Onyx for $120 per share, a 38.2% premium above Friday's close.
Opko Health Inc. (OPK), Pfizer Inc. (PFE): This Biotech Stock Looks Great for the Long Run
When you are looking to add a biotech stock to your portfolio, most of the small cap biotech stocks have a small-sized pipeline.
Is Zoetis Inc (ZTS) Worth the Premium?
After all of the hype and hoopla over Pfizer Inc.
Antares Pharma Inc (ATRS), ISIS Pharmaceuticals, Inc. (ISIS), Ligand Pharmaceuticals Inc. (LGND): 3 Pharma Stocks You Need to Watch for the Rest of 2013
It's hard to believe, but 2013 is already more than halfway over. This year has been a good one for many pharmaceutical stocks -- at least so far.
Quiksilver, Inc. (ZQK), Pfizer Inc. (PFE): Tuesday’s Top Upgrades (and Downgrades)
This series, brought to you by Yahoo! Finance, looks at which upgrades and downgrades make sense, and which ones investors should act on.
Pfizer Inc. (PFE), Thermo Fisher Scientific Inc. (TMO), Foot Locker, Inc. (FL): Shorts Are Piling Into These Stocks. Should You Be Worried?
The best thing about the stock market is that you can make money in either direction. Historically, stock indexes have tended to trend up over the long term.
Onyx Pharmaceuticals, Inc. (ONXX) Says the Price Isn’t Right
That's the message from Onyx Pharmaceuticals, Inc. (NASDAQ:ONXX) over the weekend after Amgen, Inc. (NASDAQ:AMGN) made an unsolicited offer to buy the company.
Johnson & Johnson (JNJ): Is This Pharmaceutical Giant About To Lose Its Cornerstone Drug?
What’s the worst nightmare of all pharmaceutical companies? Generics. They might as well be the grim reaper in the eyes of the brand-name pharmaceuticals.
Pfizer Inc. (PFE), Walgreen Company (WAG): A New Dividend Growth Stock
Dividend growth investing is a slow and steady process taking place over a long period of time.
Why Ligand Pharmaceuticals Inc. (LGND) Shares Popped
Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis...
Amgen, Inc. (AMGN)’s Future Is Bright
Amgen, Inc. (NASDAQ:AMGN) has gone up a lot in share price over the last few years. Amgen, Inc.
Elan Corporation, plc (ADR) (ELN), VIVUS, Inc. (VVUS), MannKind Corporation (MNKD): Three Biotech Companies to Watch This Summer
The news flow from biotech companies might slow down during the summer, but it won't stop.
Who Really, Really Wants Some More Pfizer Inc. (PFE) Stock?
An entity with deep pockets is looking to buy boatloads of Pfizer Inc. (NYSE:PFE) stock. And we're talking yacht-sized boatloads -- not canoe-sized ones.
Is the Time Ripe to Buy Johnson & Johnson (JNJ) Stock?
If you owned Johnson & Johnson (NYSE:JNJ) stock at the beginning of 2013, you're sitting atop gains of more than 20% right now.
For Allergan, Inc. (AGN) Shareholders, Will it Be Dry Eyes or Tears of Joy?
On June 24, the Food and Drug Administration issued “bioequivalence recommendations” for 15 active ingredients used in prescription medications.
Pfizer Inc. (PFE), Eli Lilly & Co. (LLY), Baxter International Inc. (BAX): Three Solid Long-Term Pharma Picks
Moreover, there is a rising demand for good healthcare in developing countries in the Asia-Pacific region.
Will Pfizer Inc. (PFE) Stock Soar or Sink for the Rest of 2013?
Pfizer Inc. (NYSE:PFE) stock is off to a fine start in 2013.
Warner Chilcott Plc (WCRX) & Actavis Inc (ACT): Can You Profit From This Pharma Tie-Up
Niche biotech company Warner Chilcott Plc (NASDAQ:WCRX) has been looking for an exit strategy ever since announcing strategic alternatives back in August 2012.
Eli Lilly & Co. (LLY), Bristol Myers Squibb Co. (BMY): Can’t Anyone Tackle Alzheimer’s?
After a series of failures, one is forced to wonder whether the medical fraternity, including the research and development wing of Eli Lilly & Co.
American Express Company (AXP), Pfizer Inc. (PFE): No End to the Dow’s Triple-Digit Win Streak
Wall Street's bounce back from last week continues today, with the Dow Jones Industrial Average (Dow Jones Indices:.DJI) looking to continue its recent run of triple-digit moves...
Pfizer Inc. (PFE), VIVUS, Inc. (VVUS): Cheap Viagra That Americans Can’t Buy
Cheap generic versions of Pfizer Inc. (NYSE:PFE)'s Viagra are coming to Europe, according the generic-drug maker Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA).
What These Ratios Tell Us About GlaxoSmithKline plc (ADR) (GSK)
These two ratios provide an indication of how successful a company is at generating profits using shareholders' funds and debt, and they have a strong influence on dividend payments...
AbbVie Inc (ABBV) Has Much More Upside Reward Than Downside Risk
For investors viewing AbbVie Inc (NYSE:ABBV) as a value play since its spin-off from Abbott Laboratories (NYSE:ABT), it is time to think again.
Raynor: What Makes Merck & Co., Inc. (MRK) an Exceptional Company
A director at Deloitte Services LP and co-author of The Three Rules: How Exceptional Companies Think, Michael Raynor joins The Fool to share his findings about what makes a company...
Why Loss of Viagra Patent Will Not Harm Pfizer Inc. (PFE)
Viagra changed the way below-the-belt jokes were told, and certainly, it empowered a lot of men in ways they couldn't have imagined. Without a doubt, Pfizer Inc.
Johnson & Johnson (JNJ): Why Might This Play Shake Up the Cancer-Drug Industry?
Medical firm Johnson & Johnson (NYSE:JNJ) recently announced a private-company acquisition that could have major implications for one of the markets in which it operates.
Sarepta Therapeutics Inc (SRPT), VIVUS, Inc. (VVUS): The Week’s Biotech Winner and Loser
The easiest route would involve the companies with the biggest share price movements.
Hedge Funds Are Betting On Pfizer Inc. (PFE)
Pfizer Inc. (NYSE:PFE) was in 81 hedge funds' portfolio at the end of the first quarter of 2013. PFE shareholders have witnessed an increase in hedge fund interest recently.
Kinder Morgan Inc (KMI), Pfizer Inc. (PFE): Want to Be a Great Investor? Maybe You Should Have Been an English Major
I recently read Robert Hagstrom's "Investing: The Last Liberal Art", a tome that has some fascinating insights for any investor. The book is full of wisdom from Charlie Munger...
Oncolytics Biotech, Inc. (USA) (ONCY): This Promising Biotech Can Triple
Cancer is one of the deadliest challenges that humans face today. Different forms of cancer have taken millions of lives all around the world.
Merck & Co., Inc. (MRK), Zoetis Inc (ZTS), Kellogg Company (K) – Shorts Are Piling Into These Stocks. Should You Be Worried?
The best thing about the stock market is that you can make money in either direction. Historically, stock indexes have tended to trend up over the long term.
